ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,115, issued on Aug. 5, was assigned to PrimeVax Immuno-Oncology (Orange, Calif.).
"Combination immunotherapies for treatment of cancer" was invented by Bruce W. Lyday (Orange, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compositions and methods for treating a disease, particularly a cancer, with an immune checkpoint modulatory agent and a strain of an Arbovirus or a strain of an Alphavirus. Also provided herein are also methods for combination therapy comprising administration of an immune checkpoint modulatory agent, tumor antigen primed dendritic cells and an Alphavirus or an Arbovirus."
The patent was filed on June ...